News Summary

Kahn Swick & Foti, LLC has begun an investigation into the proposed acquisition of scPharmaceuticals Inc. by MannKind Corporation. The firm aims to evaluate the compensation of $5.35 per share and the process leading to the acquisition to ensure shareholders are treated fairly. Shareholders are encouraged to assess their options and seek KSF’s legal consultation at no cost. With this acquisition, MannKind is looking to expand its product offerings in the healthcare market, and stakeholders are closely watching the unfolding implications.

New Orleans, LA – Kahn Swick & Foti, LLC (KSF) has initiated an investigation regarding the proposed acquisition of scPharmaceuticals Inc. by MannKind Corporation. The law firm, which is led by former Louisiana Attorney General Charles C. Foti, Jr., Esq., aims to assess the adequacy of the transaction’s price and the process that led to it. This inquiry follows the announcement that scPharmaceuticals shareholders would receive a cash compensation of $5.35 per share along with one non-tradable contingent value right (CVR) per share, potentially worth an additional $1.00 per CVR based on meeting certain regulatory and sales benchmarks.

The acquisition is structured as a tender offer, which may prompt urgency among interested parties. KSF’s investigation will focus on whether the proposed financial terms reflect scPharmaceuticals’ actual value and whether shareholders are being fairly compensated for their stakes in the company.

Investment Considerations

Shareholders of scPharmaceuticals are being encouraged to evaluate their options. Should they feel that the offer undervalues their investments, they are urged to reach out to KSF to discuss their legal rights. Notably, this consultation comes without obligation or cost, aiming to empower investors to make informed decisions during this critical period.

Contact Information

Lewis S. Kahn, the Managing Partner at KSF, is available to address inquiries from shareholders. He can be contacted via email at lewis.kahn@ksfcounsel.com or through a toll-free number at 855-768-1857. For those looking for additional updates or information regarding the ongoing investigation, KSF has made resources available on their official website.

About Kahn Swick & Foti, LLC

Founded and operated by seasoned legal professionals, KSF is known for representing clients in matters related to shareholder rights. The firm boasts a strong history of advocating for fair practices in corporate transactions. KSF also maintains a presence on numerous social media platforms including Facebook, Instagram, YouTube, TikTok, and LinkedIn, enabling them to communicate actively with interested parties.

Background on scPharmaceuticals Inc. and MannKind Corporation

scPharmaceuticals Inc., listed on NasdaqGS under the ticker SCPH, specializes in transforming injectable therapies into subcutaneous infusions, providing innovative solutions for patients and healthcare providers. Their products aim to ease the administration of certain medications while enhancing patient mobility and quality of life.

MannKind Corporation, which trades on NasdaqGM as MNKD, is dedicated to the development and commercialization of inhaled therapeutics for diseases such as diabetes and pulmonary disorders. MannKind’s acquisition of scPharmaceuticals is part of its strategy to broaden its product offerings and fulfill unmet patient needs in the healthcare market.

Conclusion

As the investigation unfolds, stakeholders will be watching closely to understand the implications of this proposed sale. Ensuring a fair valuation process will be crucial for maintaining investor confidence in both scPharmaceuticals and MannKind, as well as the broader implications for future corporate acquisitions within the sector.

Deeper Dive: News & Info About This Topic

Author: STAFF HERE NEWORLEANS WRITER

NEW ORLEANS STAFF WRITER The NEW ORLEANS STAFF WRITER represents the experienced team at HERENewOrleans.com, your go-to source for actionable local news and information in New Orleans, Orleans Parish, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as French Quarter Festival, New Orleans Jazz & Heritage Festival, and Essence Music Festival. Our coverage extends to key organizations like the New Orleans Chamber of Commerce and Greater New Orleans, Inc., plus leading businesses in energy, healthcare, and education that power the local economy such as Entergy, Ochsner Health, and Tulane University. As part of the broader HERE network, including HEREShreveport.com, we provide comprehensive, credible insights into Louisiana's dynamic landscape.

Investigation Launched into MannKind’s Acquisition of scPharmaceuticals